Quest Diagnostics, Inc. (DGX)
241.89
-1.39
(-0.57%)
USD |
NYSE |
Oct 23, 16:00
241.89
0.00 (0.00%)
After-Hours: 20:00
Quest Diagnostics Enterprise Value : 32.49B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 32.49B |
| October 22, 2026 | 32.65B |
| October 21, 2026 | 32.17B |
| October 20, 2026 | 31.97B |
| October 19, 2026 | 31.73B |
| October 16, 2026 | 31.74B |
| October 15, 2026 | 32.19B |
| October 14, 2026 | 31.56B |
| October 13, 2026 | 31.24B |
| October 12, 2026 | 31.48B |
| October 09, 2026 | 31.29B |
| October 08, 2026 | 31.28B |
| October 07, 2026 | 30.86B |
| October 06, 2026 | 31.01B |
| October 05, 2026 | 31.43B |
| October 02, 2026 | 31.55B |
| October 01, 2026 | 31.31B |
| September 30, 2026 | 31.52B |
| September 29, 2026 | 31.66B |
| September 28, 2026 | 32.28B |
| September 25, 2026 | 32.14B |
| September 24, 2026 | 32.16B |
| September 23, 2026 | 31.77B |
| September 22, 2026 | 31.96B |
| September 21, 2026 | 33.08B |
| Date | Value |
|---|---|
| September 18, 2026 | 33.25B |
| September 17, 2026 | 33.36B |
| September 16, 2026 | 33.32B |
| September 15, 2026 | 33.32B |
| September 14, 2026 | 32.31B |
| September 11, 2026 | 31.99B |
| September 10, 2026 | 31.57B |
| September 09, 2026 | 32.04B |
| September 08, 2026 | 32.04B |
| September 04, 2026 | 32.23B |
| September 03, 2026 | 32.47B |
| September 02, 2026 | 32.63B |
| September 01, 2026 | 32.12B |
| August 31, 2026 | 32.57B |
| August 28, 2026 | 32.84B |
| August 27, 2026 | 33.05B |
| August 26, 2026 | 33.09B |
| August 25, 2026 | 33.04B |
| August 24, 2026 | 32.97B |
| August 21, 2026 | 33.02B |
| August 20, 2026 | 32.68B |
| August 19, 2026 | 32.73B |
| August 18, 2026 | 32.13B |
| August 17, 2026 | 32.05B |
| August 14, 2026 | 31.92B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Labcorp Holdings, Inc. | 33.25B |
| DaVita, Inc. | 25.26B |
| OPKO Health, Inc. | 1.313B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.425B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 324.00M |
| Revenue (Quarterly) | 3.097B |
| Total Expenses (Quarterly) | 2.787B |
| EPS Diluted (Quarterly) | 2.768 |
| Gross Profit Margin (Quarterly) | 32.48% |
| Profit Margin (Quarterly) | 10.46% |
| Earnings Yield | 4.15% |
| Operating Earnings Yield | 6.45% |
| Normalized Earnings Yield | 4.553 |